Apfelberg D B, Druker D, Maser M R, White D N, Lash H, Spector P
Department of Plastic Surgery, Comprehensive Laser Center, Palo Alto Medical Foundation, CA 94301.
J Dermatol Surg Oncol. 1989 Apr;15(4):371-5. doi: 10.1111/j.1524-4725.1989.tb03241.x.
The benefits of the carbon dioxide (CO2) laser in the treatment of verruca resistant to other forms of treatment have been studied. Twenty-five patients with warts unsuccessfully treated from one to five times previously were treated with the laser, followed for a minimum of 6 months, and evaluated. Eight of these patients (32%) gained a total permanent cure. An additional five treatments resulted in a subtotal (over 75%) cure but some warts remained. Thus, 13 of 25 patients (52%) experienced complete or partially successful treatment. The CO2 laser is a valuable modality in the treatment of recalcitrant warts but cannot be expected to cure all such warts.
二氧化碳（CO₂）激光在治疗对其他治疗方式耐药的疣方面的益处已得到研究。25例先前接受过1至5次治疗但未成功的疣患者接受了激光治疗，随访至少6个月并进行评估。其中8例患者（32%）实现了完全永久性治愈。另外5例患者经治疗后达到部分治愈（超过75%），但仍有一些疣残留。因此，25例患者中有13例（52%）经历了完全或部分成功的治疗。CO₂激光是治疗顽固性疣的一种有价值的方式，但不能期望治愈所有此类疣。
